These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 512037)
21. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507 [TBL] [Abstract][Full Text] [Related]
22. [Antibodies against e-antigen in patients with HBsAg-positive liver diseases]. Thamer G; Gmelin K; Kommerell B Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():557-8. PubMed ID: 612030 [No Abstract] [Full Text] [Related]
23. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease]. Goeser T; Theilmann L Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621 [No Abstract] [Full Text] [Related]
24. [Prevalence of HLA-A and -B antigens, anti-HBc and -HBs antibodies in alcoholic hepatopathies]. Doffoël M; Tongio MM; Ledig M; Charrault A; Vetter D; North ML; Mayer S; Mandel P; Bockel R Ann Med Interne (Paris); 1985; 136(3):225-8. PubMed ID: 3875304 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis Bs antigen, antigen subtypes and hepatitis Bs antibody in Ghana. Addy PA; Minami K Afr J Med Med Sci; 1978 Sep; 7(3):123-7. PubMed ID: 108930 [TBL] [Abstract][Full Text] [Related]
26. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma. Chen DS; Sung JL; Lai MY Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625 [TBL] [Abstract][Full Text] [Related]
27. Application of a screening test for antibody the hepatitis B core antigen. Cohen BJ; Cossart YE J Clin Pathol; 1977 Aug; 30(8):709-13. PubMed ID: 599183 [TBL] [Abstract][Full Text] [Related]
28. IgA antibodies to dietary antigens in liver cirrhosis. Volta U; Bonazzi C; Bianchi FB; Baldoni AM; Zoli M; Pisi E Ric Clin Lab; 1987; 17(3):235-42. PubMed ID: 3671996 [TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases]. Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666 [TBL] [Abstract][Full Text] [Related]
30. [Demonstration of hepatitis Be-antigen and of antibodies against it (author's transl)]. Lange W; Masihi KN Dtsch Med Wochenschr; 1980 Jun; 105(23):823-6. PubMed ID: 7408655 [TBL] [Abstract][Full Text] [Related]
31. [Prevalence of antibodies against the hepatitis B virus in alcoholic liver diseases]. Natangelo R; Monarca A; Bastia A; Adelasco L; Croce G Minerva Med; 1983 Apr; 74(16):889-92. PubMed ID: 6843874 [TBL] [Abstract][Full Text] [Related]
33. Importance of markers of hepatitis B virus in alcoholic liver disease. Saunders JB; Wodak AD; Morgan-Capner P; White YS; Portmann B; Davis M; Williams R Br Med J (Clin Res Ed); 1983 Jun; 286(6381):1851-4. PubMed ID: 6407600 [TBL] [Abstract][Full Text] [Related]
34. Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease. Izumi N; Sato C; Hasumura Y; Takeuchi J Clin Exp Immunol; 1985 Sep; 61(3):585-92. PubMed ID: 3907903 [TBL] [Abstract][Full Text] [Related]
35. Deficiency of antibody formation to HBsAg in the pathogenesis of chronic hepatitis and cirrhosis? Schlicht I; Gadow J; Ortmans H; Jorno L; Gentz HD; Wolter G; Hoppe I Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):450-6. PubMed ID: 549426 [TBL] [Abstract][Full Text] [Related]
36. [e/Anti-e system in liver disease]. Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125 [TBL] [Abstract][Full Text] [Related]
37. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Rizzetto M; Canese MG; Aricò S; Crivelli O; Trepo C; Bonino F; Verme G Gut; 1977 Dec; 18(12):997-1003. PubMed ID: 75123 [TBL] [Abstract][Full Text] [Related]
38. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483 [TBL] [Abstract][Full Text] [Related]
39. Antibody to hepatitis B core antigen in chronic active hepatitis. Bories P; Coursaget P; Goudeau A; Degott C; Maupas P; Benhamou JP Br Med J; 1978 Feb; 1(6110):396-7. PubMed ID: 624027 [TBL] [Abstract][Full Text] [Related]
40. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology]. Ardito D; Bianco T; Demundo T; Loiodice L Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]